<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE root>
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:ali="http://www.niso.org/schemas/ali/1.0/" article-type="research-article" dtd-version="1.2" xml:lang="en"><front><journal-meta><journal-id journal-id-type="publisher-id">V.F.Snegirev Archives of Obstetrics and Gynecology</journal-id><journal-title-group><journal-title xml:lang="en">V.F.Snegirev Archives of Obstetrics and Gynecology</journal-title><trans-title-group xml:lang="ru"><trans-title>Архив акушерства и гинекологии им. В.Ф. Снегирева</trans-title></trans-title-group></journal-title-group><issn publication-format="print">2313-8726</issn><issn publication-format="electronic">2687-1386</issn><publisher><publisher-name xml:lang="en">Eco-Vector</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="publisher-id">697175</article-id><article-id pub-id-type="doi">10.17816/aog697175</article-id><article-id pub-id-type="edn">MTLXNP</article-id><article-categories><subj-group subj-group-type="toc-heading" xml:lang="en"><subject>Original study articles</subject></subj-group><subj-group subj-group-type="toc-heading" xml:lang="ru"><subject>Оригинальные исследования</subject></subj-group><subj-group subj-group-type="toc-heading" xml:lang="zh"><subject>Original study articles</subject></subj-group><subj-group subj-group-type="article-type"><subject>Research Article</subject></subj-group></article-categories><title-group><article-title xml:lang="en">Maternal renal and ophthalmic artery doppler parameters in predicting pregnancy-induced hypertension</article-title><trans-title-group xml:lang="ru"><trans-title>Допплерографические показатели кровотока в почечных и глазных артериях у беременных в прогнозировании гестационных гипертензивных расстройств</trans-title></trans-title-group><trans-title-group xml:lang="zh"><trans-title>孕妇肾动脉和眼动脉多普勒血流指标在预测妊娠期高血压疾病中的应用</trans-title></trans-title-group></title-group><contrib-group><contrib contrib-type="author"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0002-9569-3334</contrib-id><contrib-id contrib-id-type="spin">6062-0083</contrib-id><name-alternatives><name xml:lang="en"><surname>Bulanova</surname><given-names>Maria M.</given-names></name><name xml:lang="ru"><surname>Буланова</surname><given-names>Мария Михайловна</given-names></name><name xml:lang="zh"><surname>Bulanova</surname><given-names>Maria M.</given-names></name></name-alternatives><address><country country="RU">Russian Federation</country></address><email>mariabulanova98@gmail.com</email><xref ref-type="aff" rid="aff1"/><xref ref-type="aff" rid="aff2"/></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid">https://orcid.org/0009-0008-6757-7660</contrib-id><contrib-id contrib-id-type="spin">4953-0275</contrib-id><name-alternatives><name xml:lang="en"><surname>Shamugiya</surname><given-names>Valerian V.</given-names></name><name xml:lang="ru"><surname>Шамугия</surname><given-names>Валериан Валерианович</given-names></name><name xml:lang="zh"><surname>Shamugiya</surname><given-names>Valerian V.</given-names></name></name-alternatives><address><country country="RU">Russian Federation</country></address><bio xml:lang="en"><p>MD, Cand. Sci. (Medicine)</p></bio><bio xml:lang="ru"><p>канд. мед. наук</p></bio><bio xml:lang="zh"><p>MD, Cand. Sci. (Medicine)</p></bio><email>ShamugiyaVV@zdrav.mos.ru</email><xref ref-type="aff" rid="aff2"/></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0001-9447-110X</contrib-id><contrib-id contrib-id-type="spin">7113-6744</contrib-id><name-alternatives><name xml:lang="en"><surname>Ponimanskaya</surname><given-names>Maria A.</given-names></name><name xml:lang="ru"><surname>Пониманская</surname><given-names>Мария Александровна</given-names></name><name xml:lang="zh"><surname>Ponimanskaya</surname><given-names>Maria A.</given-names></name></name-alternatives><address><country country="RU">Russian Federation</country></address><bio xml:lang="en"><p>MD, Cand. Sci. (Medicine)</p></bio><bio xml:lang="ru"><p>канд. мед. наук</p></bio><bio xml:lang="zh"><p>MD, Cand. Sci. (Medicine)</p></bio><email>PonimanskayaMA@zdrav.mos.ru</email><xref ref-type="aff" rid="aff2"/></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid">https://orcid.org/0009-0009-8399-2271</contrib-id><contrib-id contrib-id-type="spin">2733-1037</contrib-id><name-alternatives><name xml:lang="en"><surname>Andreeva</surname><given-names>Elena Yu.</given-names></name><name xml:lang="ru"><surname>Андреева</surname><given-names>Елена Юрьевна</given-names></name><name xml:lang="zh"><surname>Andreeva</surname><given-names>Elena Yu.</given-names></name></name-alternatives><address><country country="RU">Russian Federation</country></address><email>elenaandreeva@list.ru</email><xref ref-type="aff" rid="aff2"/></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid">https://orcid.org/0009-0006-9105-5219</contrib-id><contrib-id contrib-id-type="spin">2724-6709</contrib-id><name-alternatives><name xml:lang="en"><surname>Kaiibkhanova</surname><given-names>Ksenia M.</given-names></name><name xml:lang="ru"><surname>Кайибханова</surname><given-names>Ксения Михайловна</given-names></name><name xml:lang="zh"><surname>Kaiibkhanova</surname><given-names>Ksenia M.</given-names></name></name-alternatives><address><country country="RU">Russian Federation</country></address><bio xml:lang="en"><p>MD, Cand. Sci. (Medicine)</p></bio><bio xml:lang="ru"><p>канд. мед. наук</p></bio><bio xml:lang="zh"><p>MD, Cand. Sci. (Medicine)</p></bio><email>ksepushek@mail.ru</email><xref ref-type="aff" rid="aff2"/></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0003-1397-6208</contrib-id><contrib-id contrib-id-type="spin">2105-6871</contrib-id><name-alternatives><name xml:lang="en"><surname>Panina</surname><given-names>Olga B.</given-names></name><name xml:lang="ru"><surname>Панина</surname><given-names>Ольга Борисовна</given-names></name><name xml:lang="zh"><surname>Panina</surname><given-names>Olga B.</given-names></name></name-alternatives><address><country country="RU">Russian Federation</country></address><bio xml:lang="en"><p>MD, Dr. Sci. (Medicine)</p></bio><bio xml:lang="ru"><p>д-р мед. наук, профессор</p></bio><bio xml:lang="zh"><p>MD, Dr. Sci. (Medicine)</p></bio><email>olgapanina@yandex.ru</email><xref ref-type="aff" rid="aff1"/></contrib></contrib-group><aff-alternatives id="aff1"><aff><institution xml:lang="en">Lomonosov Moscow State University</institution></aff><aff><institution xml:lang="ru">Московский государственный университет им. М.В. Ломоносова</institution></aff><aff><institution xml:lang="zh">Lomonosov Moscow State University</institution></aff></aff-alternatives><aff-alternatives id="aff2"><aff><institution xml:lang="en">City Clinical Hospital No. 67 n.a. L. A. Vorokhobov</institution></aff><aff><institution xml:lang="ru">Городская клиническая больница № 67 им. Л.А. Ворохобова</institution></aff><aff><institution xml:lang="zh">City Clinical Hospital No. 67 n.a. L. A. Vorokhobov</institution></aff></aff-alternatives><pub-date date-type="preprint" iso-8601-date="2026-02-28" publication-format="electronic"><day>28</day><month>02</month><year>2026</year></pub-date><pub-date date-type="pub" iso-8601-date="2026-04-21" publication-format="electronic"><day>21</day><month>04</month><year>2026</year></pub-date><volume>13</volume><issue>1</issue><issue-title xml:lang="en"/><issue-title xml:lang="ru"/><issue-title xml:lang="zh"/><fpage>59</fpage><lpage>71</lpage><history><date date-type="received" iso-8601-date="2025-11-28"><day>28</day><month>11</month><year>2025</year></date><date date-type="accepted" iso-8601-date="2025-12-30"><day>30</day><month>12</month><year>2025</year></date></history><permissions><copyright-statement xml:lang="en">Copyright ©; 2026, Eco-Vector</copyright-statement><copyright-statement xml:lang="ru">Copyright ©; 2026, Эко-Вектор</copyright-statement><copyright-statement xml:lang="zh">Copyright ©; 2026, Eco-Vector</copyright-statement><copyright-year>2026</copyright-year><copyright-holder xml:lang="en">Eco-Vector</copyright-holder><copyright-holder xml:lang="ru">Эко-Вектор</copyright-holder><copyright-holder xml:lang="zh">Eco-Vector</copyright-holder><ali:free_to_read xmlns:ali="http://www.niso.org/schemas/ali/1.0/" start_date="2028-04-21"/><license><ali:license_ref xmlns:ali="http://www.niso.org/schemas/ali/1.0/">https://eco-vector.com/for_authors.php#07</ali:license_ref></license></permissions><self-uri xlink:href="https://archivog.com/2313-8726/article/view/697175">https://archivog.com/2313-8726/article/view/697175</self-uri><abstract xml:lang="en"><p><bold>BACKGROUND</bold><bold>:</bold> Pregnancy-induced hypertension is one of the leading causes of maternal and perinatal morbidity and mortality. Identifying high-risk patients enables timely prevention of this complication. Existing models can predict individual risk of pregnancy-induced hypertension with up to 80% accuracy, indicating that additional markers and risk factors need to be identified to improve their performance.</p> <p><bold>AIM</bold><bold>:</bold> The work aimed to assess the relationship between maternal renal and ophthalmic artery Doppler parameters in the first and second trimesters and the risk of pregnancy-induced hypertension.</p> <p><bold>METHODS</bold><bold>:</bold> A prospective, single-center observational study was conducted. During the first and second prenatal screenings, the renal (resistance index) and ophthalmic (resistance index, pulsation index, velocity, peak ratio [PR], and DV/P2) artery Doppler parameters were additionally assessed. The course of pregnancy and its outcomes were then assessed, and the examined blood flow parameters were compared between patients with uncomplicated pregnancy and those with pregnancy-induced hypertension.</p> <p><bold>RESULTS</bold><bold>:</bold> The study included 353 pregnant women, with 135 receiving a follow-up examination in the second trimester. Pregnancy outcomes were reported for 324 patients who were initially included in the study. Pregnancy-induced hypertension was reported in 32 patients. These patients had significantly higher body mass index and systolic, diastolic, and mean blood pressure (<italic>p</italic> &lt; 0.001 for all). Moreover, they had higher average and maximum PR values (<italic>p</italic> = 0.036 and <italic>p</italic> = 0.036, respectively) and lower average and maximum DV/P2 values (<italic>p</italic> = 0.041 and <italic>p</italic> = 0.015, respectively) at 19–21 weeks of pregnancy. The risk of pregnancy-induced hypertension was 2.4 and 3.4 times higher in patients with PR &gt; 0.55 in the first trimester and PR &gt; 0.60 in the second trimester, respectively. Furthermore, the risk of pregnancy-induced hypertension was 7.3 times higher in patients with DV/P2 &lt; 0.90 in the second trimester.</p> <p><bold>CONCLUSION</bold><bold>:</bold> The study identified distinctive characteristics of the ophthalmic artery blood flow in patients with pregnancy-induced hypertension. Further research is needed to assess the role of these patterns in predicting individual risks of pregnancy complications.</p></abstract><trans-abstract xml:lang="ru"><p><bold>Обоснование.</bold> Гипертензивные расстройства беременности являются одними из ведущих причин материнской и детской заболеваемости и смертности. Формирование групп высокого риска развития этих осложнений позволяет своевременно провести профилактику их развития. Существующие модели определения индивидуального риска развития данных осложнений обладают точностью до 80%, поэтому остаётся актуальной задача по улучшению данного показателя за счёт дополнительных маркёров и факторов риска.</p> <p><bold>Цель исследования. </bold>Оценка взаимосвязи между допплерографическими показателями кровотока в глазной и почечной артериях у беременных в первом и втором триместрах и риском развития гипертензивных расстройств гестации.</p> <p><bold>Методы. </bold>Исследование является проспективным наблюдательным одноцентровым. При раннем и втором пренатальных скринингах у беременных дополнительно оценивали допплерографические показатели кровотока в почечных (индекс резистентности) и глазных (индекс резистентности, пульсационный индекс, значения скоростей и их отношения — PR и DV/P2) артериях. Далее анализировали течение беременности и её исход, затем сравнивали исследуемые показатели кровотока у пациенток с неосложнённой беременностью и у пациенток с гестационными гипертензивными расстройствами.</p> <p><bold>Результаты.</bold> В исследование были включены 353 беременные, во втором триместре обследованы 135 из них. Информацию об исходах беременности получили у 324 пациенток из изначально включённых в исследование. У 32 беременных диагностированы гипертензивные расстройства беременности, у них отмечались статистически значимо более высокие значения индекса массы тела, систолического, диастолического и среднего артериального давления (для всех <italic>p</italic> &lt; 0,001), а также более высокие усреднённые и максимальные значения допплерографического показателя PR (<italic>p</italic> = 0,036 и <italic>p</italic> = 0,036 соответственно) и более низкие усреднённые и максимальные значения показателя DV/P2 (<italic>p</italic> = 0,041 и <italic>p</italic> = 0,015 соответственно) при исследовании на сроке беременности 19–21 неделя. Риск развития гипертензивных расстройств беременности был в 2,4 и в 3,4 раза выше у пациенток с PR &gt; 0,55 в первом триместре и PR &gt; 0,60 во втором триместре соответственно. Риск развития гипертензивных осложнений был в 7,3 раза выше в группе пациенток со значениями показателя DV/P2 во втором триместре &lt; 0,90.</p> <p><bold>Заключение.</bold> Выявлены отличительные особенности показателей кровотока в глазной артерии у пациенток с гипертензивными расстройствами беременности. Обнаруженные закономерности представляют интерес для дальнейшего изучения их роли в прогнозировании индивидуальных рисков развития осложнений беременности.</p></trans-abstract><trans-abstract xml:lang="zh"><p><bold>论证。</bold>妊娠期高血压疾病是导致孕产妇和围产儿发病率及死亡率的主要原因之一。确定这些并发症的高风险人群有助于及时进行预防。现有的评估这些并发症个体风险的模型准确率可达80%，因此，通过引入额外的标志物和风险因素来提高这一指标仍是一项紧迫的任务。</p> <p><bold>目的。</bold>评估孕早期和孕中期孕妇眼动脉和肾动脉多普勒血流指标与妊娠期高血压疾病发生风险之间的关系。</p> <p><bold>方法。</bold>本研究为一项前瞻性观察性单中心研究。在孕早期和孕中期产前筛查期间，额外评估了孕妇肾动脉（阻力指数）和眼动脉（阻力指数、搏动指数、血流速度值及其比值 — — PR和DV/P2）的多普勒血流指标。随后分析了妊娠过程及其结局，并比较了正常妊娠患者与妊娠期高血压疾病患者的血流指标。</p> <p><bold>结果。</bold>该研究共纳入353名孕妇，其中135名在妊娠中期接受了检查。在最初纳入研究的患者中，获得了324名患者的妊娠结局信息。32名孕妇被诊断患有妊娠期高血压疾病，在孕19–21周的检查中，她们的体重指数、收缩压、舒张压和平均动脉压均显著升高（所有 p &lt; 0.001），此外，PR指标的平均值和最大值较高（分别为p = 0.036和p = 0.036），而DV/P2指标的平均值和最大值较低（分别为p = 0.041和p = 0.015）。 妊娠早期PR &gt; 0.55和妊娠中期PR &gt; 0.60的患者，发生妊娠期高血压疾病的风险分别高出2.4倍和3.4倍。妊娠中期DV/P2指标值 &lt; 0.90的患者组，发生高血压并发症的风险高出7.3倍。</p> <p><bold>结论。</bold>揭示了妊娠期高血压疾病患者眼动脉血流指标的特征。发现的规律对于进一步研究其在预测个体妊娠并发症风险中的作用具有重要意义。</p></trans-abstract><kwd-group xml:lang="en"><kwd>pregnancy-induced hypertension</kwd><kwd>pre-eclampsia</kwd><kwd>ophthalmic artery Doppler</kwd><kwd>renal artery Doppler</kwd><kwd>prenatal screening</kwd></kwd-group><kwd-group xml:lang="ru"><kwd>гипертензивные расстройства беременности</kwd><kwd>преэклампсия</kwd><kwd>допплерография сосудов глаза</kwd><kwd>допплерография почечных сосудов</kwd><kwd>пренатальный скрининг</kwd></kwd-group><kwd-group xml:lang="zh"><kwd>妊娠期高血压疾病</kwd><kwd>子痫前期</kwd><kwd>眼部血管多普勒超声</kwd><kwd>肾血管多普勒超声</kwd><kwd>产前筛查</kwd></kwd-group><funding-group/></article-meta></front><body></body><back><ref-list><ref id="B1"><label>1.</label><mixed-citation>Yang Y, Le Ray I, Zhu J, et al. Preeclampsia prevalence, risk factors, and pregnancy outcomes in Sweden and China. JAMA Netw Open. 2021;4(5):E218401. doi: 10.1001/jamanetworkopen.2021.8401. EDN: WDWZIO</mixed-citation></ref><ref id="B2"><label>2.</label><mixed-citation>Wilson BJ, Watson MS, Prescott GJ, et al. Hypertensive diseases of pregnancy and risk of hypertension and stroke in later life: results from cohort study. BMJ. 2003;326(7394):845–849. doi: 10.1136/bmj.326.7394.845</mixed-citation></ref><ref id="B3"><label>3.</label><mixed-citation>Orosz L, Orosz G, Veress L, et al. Screening for preeclampsia in the first trimester of pregnancy in routine clinical practice in Hungary. J Biotechnol. 2019;300:11–19. doi: 10.1016/j.jbiotec.2019.04.017</mixed-citation></ref><ref id="B4"><label>4.</label><mixed-citation>Prasad S, Sahota DS, Vanamail P, et al. Performance of Fetal Medicine Foundation algorithm for first trimester preeclampsia screening in an indigenous south Asian population. BMC Pregnancy Childbirth. 2021;21(1):805. doi: 10.1186/s12884-021-04283-6EDN: KOKYFO</mixed-citation></ref><ref id="B5"><label>5.</label><mixed-citation>Cuenca-Gómez D, De Paco Matallana C, Rolle V, et al. Comparison of different methods of first-trimester screening for preterm pre-eclampsia: cohort study. Ultrasound Obstet Gynecol. 2024;64(1):57–64. doi: 10.1002/uog.27622 EDN: QDLBQT</mixed-citation></ref><ref id="B6"><label>6.</label><mixed-citation>Gana N, Sarno M, Vieira N, et al. Ophthalmic artery Doppler at 11–13 weeks’ gestation in prediction of pre-eclampsia. Ultrasound Obstet Gynecol. 2022;59(6):731–736. doi: 10.1002/uog.24914 EDN: FSMWIC</mixed-citation></ref><ref id="B7"><label>7.</label><mixed-citation>Kalafat E, Laoreti A, Khalil A, et al. Ophthalmic artery Doppler for prediction of pre-eclampsia: systematic review and meta-analysis. Ultrasound Obstet Gynecol. 2018;51(6):731–737. doi: 10.1002/uog.19002</mixed-citation></ref><ref id="B8"><label>8.</label><mixed-citation>Maryanova TA, Chechneva MА, Klimova IV, et al. Doppler of renal blood flow in renal pathology: chronic kidney disease and preeclampsia. Poliklinika. 2015;(6-1):36–39. EDN: VLGCNB</mixed-citation></ref><ref id="B9"><label>9.</label><mixed-citation>Freydin AO, Klimkin AS, Petrov SV. Hemodynamic features of renal blood flow in the first trimester of physiological pregnancy. Trudniy Patsient. 2015;13(8-9):10–11. EDN: XEPVRJ</mixed-citation></ref><ref id="B10"><label>10.</label><mixed-citation>Markovic VM, Mikovic Z, Djukic M, et al. Doppler parameters of maternal renal blood flow in normal pregnancy. Clin Exp Obstet Gynecol. 2013;40(1):70–73.</mixed-citation></ref><ref id="B11"><label>11.</label><mixed-citation>Buchbinder A, Sibai BM, Caritis S, et al. Adverse perinatal outcomes are significantly higher in severe gestational hypertension than in mild preeclampsia. Am J Obstet Gynecol. 2002;186(1):66–71. doi: 10.1067/mob.2002.120080</mixed-citation></ref><ref id="B12"><label>12.</label><mixed-citation>Duley L. The global impact of pre-eclampsia and eclampsia. Semin Perinatol. 2009;33(3):130–137. doi: 10.1053/j.semperi.2009.02.010</mixed-citation></ref><ref id="B13"><label>13.</label><mixed-citation>Liberati M, Rotmensch S, Zannolli P, et al. Doppler velocimetry of maternal renal interlobar arteries in pregnancy-induced hypertension. Int J Gynaecol Obstet. 1994;44(2):129–133. doi: 10.1016/0020-7292(94)90066-3</mixed-citation></ref><ref id="B14"><label>14.</label><mixed-citation>Thaler I, Weiner Z, Itskovitz J. Renal artery flow velocity waveforms in normal and hypertensive pregnant women. Am J Hypertens. 1992;5(6 Pt 1):402–405. doi: 10.1093/ajh/5.6.402</mixed-citation></ref><ref id="B15"><label>15.</label><mixed-citation>de Aquino LO, Leite HV, Cabral ACV, et al. Doppler flowmetry of ophthalmic arteries for prediction of pre-eclampsia. Rev Assoc Med Bras (1992). 2014;60(6):538–541. doi: 10.1590/1806-9282.60.06.011</mixed-citation></ref><ref id="B16"><label>16.</label><mixed-citation>Sapantzoglou I, Wright A, Arozena MG, et al. Ophthalmic artery Doppler in combination with other biomarkers in prediction of pre-eclampsia at 19–23 weeks’ gestation. Ultrasound Obstet Gynecol. 2021;57(1):75–83. doi: 10.1002/uog.23528 EDN: HILFQV</mixed-citation></ref><ref id="B17"><label>17.</label><mixed-citation>Lau KGY, Kountouris E, Salazar-Rios L, et al. Prediction of adverse outcome by ophthalmic artery Doppler and angiogenic markers in pregnancies with new onset hypertension. Pregnancy Hypertens. 2023;34:110–115. doi: 10.1016/j.preghy.2023.10.001 EDN: EJUQWX</mixed-citation></ref><ref id="B18"><label>18.</label><mixed-citation>Gurgel Alves JA, Praciano De Sousa PC, Bezerra Maia E Holanda Moura S, et al. First-trimester maternal ophthalmic artery Doppler analysis for prediction of pre-eclampsia. Ultrasound Obstet Gynecol. 2014;44(4): 411–418. doi: 10.1002/uog.13338</mixed-citation></ref><ref id="B19"><label>19.</label><mixed-citation>Kusuma RA, Nurdiati DS, Al Fattah AN, et al. Ophthalmic artery Doppler for pre-eclampsia prediction at the first trimester: a Bayesian survival-time model. J Ultrasound. 2023;26(1):155–162. doi: 10.1007/s40477-022-00697-w EDN: JOJGIJ</mixed-citation></ref><ref id="B20"><label>20.</label><mixed-citation>Nicolaides KH, Sarno M, Wright A. Ophthalmic artery Doppler in the prediction of preeclampsia. Am J Obstet Gynecol. 2022;226(2S):S1098– S1101. doi: 10.1016/j.ajog.2020.11.039 EDN: CGZOLK</mixed-citation></ref><ref id="B21"><label>21.</label><mixed-citation>Praciano de Souza PC, Gurgel Alves JA, Bezerra Maia E Holanda Moura S, et al. Second trimester screening of preeclampsia using maternal characteristics and uterine and ophthalmic artery doppler. Ultraschall Med. 2018;39(2):190–197. doi: 10.1055/s-0042-104649</mixed-citation></ref></ref-list></back></article>
